 Back to Annual Meeting
|
|
Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
Abstract #156823
Audio (mp3) recordingAnastasia Fisher, RN, DNSc and Diane Hatton, RN, APRN, BC, DNS. Hahn School of Nursing and Health Science, University of San Diego, 5998 Alcala Park, San Diego, CA 92110, 619-260-7698, anastasia5@cox.net
Adequate health care is one of the most pressing problems facing incarcerated women in the US. Co-payment for health in jails and prisons is a poorly understood policy impacting women's access to health care. Virtually no nursing research explores this topic; yet nurses represent the largest group of health professionals practicing in jails and prisons and directly or indirectly implement this policy. This study aimed to: a) Analyze women prisoners' use of co-payment for health care; b) Analyze how co-payment affects women prisoners' access to health care; and c) Identify how women prisoners view the impact of co-payment on their health. Using focus groups and individual interviews with 30 previously incarcerated women, this community-based participatory research developed an explanatory theory of the impact of co-payment policies on women prisoners' access to health care. It provides knowledge for nurses and other stakeholders about how co-payment policies impact women prisoners' health; and is significant for its focus on disenfranchised women, giving visibility to those who are typically excluded from the dialogue on policies that impact their lives.
Learning Objectives:
- Describe the co-payment policy for health care in jails and prisons in the US.
- Identify the impact of the co-payment policy on the health of women prisoners.
- Discuss the implications of this policy for women prisoners and the community.
Keywords: Access to Health Care, Prisoners Health Care
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA